Back To Blog

Opinion: A UN meeting on TB is at best a means to more important ends

Posted in: Healthcare system, Latest, TB, TB

On September 22 ministers, heads of state, and other officials from around the world will gather in New York for the second United Nations High-Level Meeting on TB. Yet, a few months ago it was not the governments these officials represent, but two philanthropies that stepped in to ensure arguably the most important TB trial of the decade has the funding needed to proceed. Marcus Low contrasts commitments made at the previous UN High-Level Meeting on TB with recent data on funding for TB research and asks what this tells us about the state of the global response to an age-old killer.

Read More

Funding secured for massive TB vaccine trial

Posted in: Latest, TB, TB

A massive and much-anticipated phase 3 trial of an experimental tuberculosis (TB) vaccine is set to proceed after funding for it has been secured from two large philanthropies. If the trial’s findings are positive, the vaccine is likely to become the first new TB vaccine in over a hundred years to be widely used. Marcus Low reports.

Read More

Face to face: Prof Muki Shey on his journey from Cameroon to doing cutting-edge TB research

Posted in: Healthcare Workers, Latest, TB, TB

On 9 March, Professor Muki Shey received a silver award from the South African Medical Research Council for his “outstanding contribution to health research”. Shey is spearheading research into TB in healthcare workers from around Cape Town, scanning for those who over at least five years of high exposure to the disease at hospitals or clinics have never been infected. Biénne Huisman spoke to him about his journey from the North West of Cameroon to a lab at UCT and the value of ploughing back to help develop the next generation.

Read More

In-depth: SA at cutting edge of TB vaccine research

Posted in: Latest, TB, TB

It is a hundred years since the BCG vaccine, the only registered vaccine proven to offer some protection against tuberculosis (TB), was first used in people. Now researchers in South Africa are at the forefront of clinical trials testing experimental new TB vaccines. Adele Baleta reports.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

Posted in: Latest, TB

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More